Back to News
Market Impact: 0.35

KORU Medical Secures EU MDR Certification for Freedom60 Infusion Pump

KRMD
Regulation & LegislationHealthcare & BiotechProduct LaunchesCompany FundamentalsTechnology & Innovation

KRMD secured EU MDR certification for its Freedom60 Infusion Pump, enabling broader commercial access across the European Union. The regulatory milestone materially improves the device’s route to market and should accelerate adoption of patient-friendly home infusion solutions, supporting incremental EU sales and revenue growth. Expect increased commercialization activity and faster penetration in the home infusion segment over the next 12–24 months.

Analysis

KRMD secured EU MDR certification for its Freedom60 Infusion Pump, enabling broader commercial access across the European Union. The regulatory milestone materially improves the device’s route to market and should accelerate adoption of patient-friendly home infusion solutions, supporting incremental EU sales and revenue growth. Expect increased commercialization activity and faster penetration in the home infusion segment over the next 12–24 months.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Demo

Market Sentiment

Overall Sentiment

moderately positive

Sentiment Score

0.35

Ticker Sentiment

KRMD0.40